Key result
This review summarizes the use of temporary and permanent cardiac resynchronization therapy for managing electromechanical dyssynchrony in patients with congenital heart disease.
Why the study?
Does temporary and permanent cardiac resynchronisation therapy improve outcomes in patients with congenital heart disease?
Does temporary and permanent cardiac resynchronisation therapy improve outcomes in patients with congenital heart disease?
This review highlights that while CRT is a standard class I therapy for typical heart failure, emerging evidence from retrospective series suggests it may also be beneficial for managing acute and chronic ventricular failure in patients with congenital heart disease.
No takes yet. Share an insight, caveat, or question.
May support CRT consideration in congenital heart disease with dyssynchrony; leaves open need for prospective trials.
Jan Janoušek (2009) conducted a review in Congenital heart disease. Cardiac resynchronisation therapy (CRT) was evaluated. This review summarizes the use of temporary and permanent cardiac resynchronization therapy for managing electromechanical dyssynchrony in patients with congenital heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: